Header

BUY LIFE SCIENCE REPORTS

PharmaVision offers a comprehensive choice of high quality, insightful reports which identify key trends, future innovations, and growth opportunities. Our reports cover the life science arena including pharmaceuticals, healthcare, diagnostics, drug delivery, emerging R&D technologies and consumer nutrition.

FEATURED REPORT

Featured Reports Icon

Alexion Pharmaceuticals, Inc.: Focus on ultra-rare diseases as a revenue and profit driver

Industry leaders continue to acquire business to expand their product pipelines and global reach. Merck announced its decision to acquire Idenix Pharmaceuticals for $3.85bn to gain access to its hepatitis C portfolio (IDX21437, IDX21459 and NS5A); Roche acquired Genia Technologies to strengthen its NGS technology and Teva acquired Labrys Biologics anti migraine treatment LBR-101 for $825mn. In June, GSK entered into a collaborative and licensing agreement with Adaptimmune triggering multiple cancer programs and MarcoGenics and Takeda entered a strategic alliance to develop MGD010.

FREE WHITE PAPER

Free White Paper

Factors Currently Diving Pharmaceutical Growth in the Middle East

During the last decade the pharmaceutical industry has been looking towards the emerging economies to expand its global footprint and drive future growth. This white paper focuses on the potential opportunities for investment in the Middle East, particularly with respect to Bahrain, Saudi Arabia and the United Arab Emirates.

EVENTS 2014

Events Icon

3rd Annual Conference on Cancer Vaccines

15th Sep 2014 - 16th Sep 2014